NO306949B1 - Azacykliske eller azabicykliske forbindelser samt farmasoeytiske preparater inneholdende slike forbindelser - Google Patents

Azacykliske eller azabicykliske forbindelser samt farmasoeytiske preparater inneholdende slike forbindelser

Info

Publication number
NO306949B1
NO306949B1 NO954239A NO954239A NO306949B1 NO 306949 B1 NO306949 B1 NO 306949B1 NO 954239 A NO954239 A NO 954239A NO 954239 A NO954239 A NO 954239A NO 306949 B1 NO306949 B1 NO 306949B1
Authority
NO
Norway
Prior art keywords
compounds
azacyclic
well
pharmaceutical preparations
preparations containing
Prior art date
Application number
NO954239A
Other languages
English (en)
Norwegian (no)
Other versions
NO954239D0 (no
NO954239L (no
Inventor
Charles Arthur Alt
Leander Merritt
Charles Howard Mitch
Gary Anthony Rhodes
Roger Lewis Robey
Eldon Eugene Van Meter
John Stanley Ward
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO954239D0 publication Critical patent/NO954239D0/no
Publication of NO954239L publication Critical patent/NO954239L/no
Publication of NO306949B1 publication Critical patent/NO306949B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO954239A 1994-10-24 1995-10-23 Azacykliske eller azabicykliske forbindelser samt farmasoeytiske preparater inneholdende slike forbindelser NO306949B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32776694A 1994-10-24 1994-10-24
US44367395A 1995-06-01 1995-06-01

Publications (3)

Publication Number Publication Date
NO954239D0 NO954239D0 (no) 1995-10-23
NO954239L NO954239L (no) 1996-04-25
NO306949B1 true NO306949B1 (no) 2000-01-17

Family

ID=26986055

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954239A NO306949B1 (no) 1994-10-24 1995-10-23 Azacykliske eller azabicykliske forbindelser samt farmasoeytiske preparater inneholdende slike forbindelser

Country Status (21)

Country Link
US (6) US5929247A (fr)
EP (1) EP0709381A1 (fr)
JP (1) JPH08225575A (fr)
KR (1) KR960014125A (fr)
CN (1) CN1048986C (fr)
AU (1) AU705047B2 (fr)
BR (1) BR9504509A (fr)
CA (1) CA2161176A1 (fr)
CO (1) CO4480103A1 (fr)
CZ (1) CZ275995A3 (fr)
FI (1) FI955051A (fr)
HU (1) HUT76347A (fr)
IL (1) IL115717A0 (fr)
NO (1) NO306949B1 (fr)
NZ (1) NZ280300A (fr)
PE (1) PE12697A1 (fr)
PL (1) PL311077A1 (fr)
RU (1) RU2158262C2 (fr)
TR (1) TR199501305A2 (fr)
TW (1) TW420680B (fr)
YU (1) YU66895A (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998404A (en) * 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US6040442A (en) * 1995-06-01 2000-03-21 Eli Lilly And Company Process for preparing 1,2,5-thiadiazole containing ethers
US5767280A (en) * 1995-06-01 1998-06-16 Eli Lilly And Company Process for making heterocyclic compounds
US5852037A (en) * 1995-11-13 1998-12-22 Eli Lilly And Company Method for treating anxiety
US5998434A (en) * 1995-12-06 1999-12-07 Eli Lilly And Company Composition for treating pain
AU2152497A (en) * 1996-03-19 1997-10-10 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US6117883A (en) * 1996-04-23 2000-09-12 Eli Lilly And Company Heterocyclic compounds
JP2000509042A (ja) * 1996-04-23 2000-07-18 イーライ・リリー・アンド・カンパニー ヘテロサイクリック化合物群
JP2000509045A (ja) * 1996-04-23 2000-07-18 イーライ・リリー・アンド・カンパニー 複素環式化合物
EP0912183A4 (fr) * 1996-04-23 1999-08-04 Lilly Co Eli Composes heterocycliques
JP2000509044A (ja) * 1996-04-23 2000-07-18 イーライ・リリー・アンド・カンパニー ヘテロサイクリック化合物群
US6069159A (en) * 1996-05-10 2000-05-30 Eli Lilly And Company Heterocyclic compounds
ES2171838T3 (es) * 1996-08-01 2002-09-16 Lilly Co Eli Uso de 3-(4-hexiloxi-1,2,5-tiadiazol-3-il)-1,2,5,6-tetrahidro-1-metilpiridina (xanomelina) para el tratamiento del trastorno bipolar.
AU7871498A (en) * 1996-12-20 1998-07-17 Novo Nordisk A/S A method of treating hypercholesterolemia and related disorders
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US6620940B1 (en) 1998-08-20 2003-09-16 Eli Lilly And Company Palladium-catalyzed cross-coupling chemistry on 3-chloro-4-halo-1,2,5-thiadiazole
EP1189902B1 (fr) * 1999-06-04 2003-08-27 Eli Lilly And Company 7-oxo-2-azabicyclo[2.2.1]heptanes servant d'antagonistes selectifs du recepteur muscarinique
US6392329B1 (en) * 1999-10-12 2002-05-21 Face International Corp. Piezoelectric vibrating apparatus
US20050245567A1 (en) * 2002-08-14 2005-11-03 Dan Peters Novel quinuclidine derivatives and their use
EP1549624B1 (fr) * 2002-10-08 2009-05-13 The Scripps Research Institute Inhibiteurs d'amide hydrolase d'acide gras
US20070021404A1 (en) * 2003-06-24 2007-01-25 Dan Peters Novel aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US7750022B2 (en) * 2003-08-13 2010-07-06 Neurosearch A/S Quinuclidine derivatives and their pharmaceutical use
US20050137398A1 (en) * 2003-12-22 2005-06-23 Jianguo Ji 3-Quinuclidinyl heteroatom bridged biaryl derivatives
US7309699B2 (en) 2003-12-22 2007-12-18 Abbott Laboratories 3-Quinuclidinyl amino-substituted biaryl derivatives
US20050137203A1 (en) * 2003-12-22 2005-06-23 Jianguo Ji 3-quinuclidinyl amino-substituted biaryl derivatives
US7241773B2 (en) 2003-12-22 2007-07-10 Abbott Laboratories 3-quinuclidinyl heteroatom bridged biaryl derivatives
US7674899B2 (en) 2004-02-04 2010-03-09 Neurosearch A/S Dimeric azacyclic compounds and their use
US20090156808A1 (en) * 2004-12-20 2009-06-18 Alfio Borghese Processes for the preparation of 3,4-substituted-1,2,5-thiadiazoles and intermediates thereof
EP2258359A3 (fr) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
JP2009506069A (ja) * 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
WO2008030651A1 (fr) 2006-09-08 2008-03-13 Braincells, Inc. Combinaisons contenant un dérivé de 4-acylaminopyridine
US20080105340A1 (en) * 2006-11-02 2008-05-08 Huff Philip A Heat Treatment Method of Inlaid Pressure Vessels
US20080078081A1 (en) * 2006-09-28 2008-04-03 Huff Philip A High pressure-rated ram blowout preventer and method of manufacture
US7849599B2 (en) * 2006-09-28 2010-12-14 Hydril Usa Manufacturing Llc Imputing strength gradient in pressure vessels
US20080105341A1 (en) * 2006-11-02 2008-05-08 Huff Philip A Heat treatment of inlaid pressure vessels
US7721401B2 (en) * 2006-09-28 2010-05-25 Hydril Usa Manufacturing Llc Reinforcement of irregular pressure vessels
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
KR20100090706A (ko) * 2007-11-21 2010-08-16 아보트 러보러터리즈 니코틴성 아세틸콜린 수용체 활성 조절제로서의 비아릴 치환된 아자바이사이클릭 알칸 유도체
AU2011305462B2 (en) 2010-09-23 2015-11-26 Abbvie Bahamas Ltd. Monohydrate of an azaadamantane derivative
RU2014124531A (ru) * 2012-01-25 2016-04-10 Демеркс, Инк. (1r,4r) 7-оксо-2-азабицикло[2.2.2]окт-5-ен и его производные
WO2017004485A1 (fr) 2015-07-02 2017-01-05 Raptor Pharmaceuticals Inc. Analogues de la cystéamine résistant à l'ado et utilisations de ceux-ci

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247193A (en) * 1966-04-19 And the preparatpdn
US3419573A (en) * 1965-10-15 1968-12-31 Merck & Co Inc 3-chloro-4-oxy-1,2,5-thiadiazoles, and a process for preparing same
US3488360A (en) * 1966-08-01 1970-01-06 Merck & Co Inc 1,2,5-thiadiazoles and methods for preparing same
AT266827B (de) * 1966-11-14 1968-12-10 Chemie Linz Ag Verfahren zur Herstellung von neuen Derivaten des 3-Amino-1,2,5-thiadiazols
AT281018B (de) * 1968-04-03 1970-05-11 Chemie Linz Ag Verfahren zur Herstellung von 3-Amino-4-brom-1,2,5-thiadiazol
US3657237A (en) * 1968-05-22 1972-04-18 Frosst & Co Charles E Process for making 1 2 5-thiadiazoles in the sinister configuration
GB1253709A (en) * 1968-05-22 1971-11-17 Frosst & Co Charles E Thiadiazole derivatives
DE1914496C3 (de) * 1969-03-21 1974-08-01 Lentia Gmbh, Chem. U. Pharm. Erzeugnisse - Industriebedarf, 8000 Muenchen Verfahren zur Herstellung von 1,2,5 -Thiadiazolderivaten
US3619370A (en) * 1969-04-21 1971-11-09 Frosst & Co Charles E Microbial reduction of thiadiazoles
AT294081B (de) * 1969-09-18 1971-11-10 Chemie Linz Ag Verfahren zur Herstellung von Sulfanilamido-1,2,5,-thiadiazolderivaten
NL7109460A (fr) * 1970-07-22 1972-01-25
US3729477A (en) * 1971-09-09 1973-04-24 Frosst & Co Charles E Certain 4-(3-amino-2-hydroxypropoxy)-1,2,5-thiadiazole-3-carboxamides
JPS4913176A (fr) * 1972-06-03 1974-02-05
FI76795C (fi) * 1979-09-04 1988-12-12 Bristol Myers Co Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 3,4-disubstituerade 1,2,5-tiadiazol-1-oxider och -1,1-dioxider samt nya mellanprodukter.
CA1219587A (fr) * 1981-12-14 1987-03-24 Norman P. Jensen Hydroxybenzylaminobenzenes comme agent anti-inflammatoire
US4508725A (en) * 1982-12-22 1985-04-02 American Hospital Supply Corporation Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives
IL83275A (en) * 1986-09-08 1994-02-27 Novo Nordisk As Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them
CA1307790C (fr) * 1987-08-04 1992-09-22 Ian Anthony Cliffe Ethers
NZ225999A (en) * 1987-09-10 1992-04-28 Merck Sharp & Dohme Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5482916A (en) * 1989-08-22 1996-01-09 Tosoh Corporation Thiadiazole derivatives and herbicide compositions containing same
EP0414511A1 (fr) * 1989-08-22 1991-02-27 Tosoh Corporation Dérivés de thiadiazole et compositions herbicides les contenant
DK0456519T3 (da) * 1990-05-11 1994-11-07 Sankyo Co Piperidyloxy- og quinuclidinyloxyisoxazolderivater, deres fremstilling og deres terapeutiske anvendelse
US5418240A (en) * 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
DK198490D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198390D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
JPH04182403A (ja) * 1990-11-16 1992-06-30 Tosoh Corp チアジアゾール誘導体を有効成分として含有する殺菌剤
US5051420A (en) * 1991-03-04 1991-09-24 A. H. Robins Company, Incorporated 4-substituted-3-1H-imidazol-1-,2,5-thiadiazoles as antiarrhythmic agents
GB2258652A (en) * 1991-08-15 1993-02-17 Merck Sharp & Dohme Pharmaceutically useful azabicyclic oxime ethers
WO1993020814A1 (fr) * 1992-04-22 1993-10-28 Karin Elisabeth Peuschel Action immunostimulante et par consequent antivirale des composes 4-[3-(aminosubst.)-2-hydroxypropoxy]-1,2,5-thiadiazol
DK154092D0 (da) * 1992-12-23 1992-12-23 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
WO1994018201A1 (fr) * 1993-02-12 1994-08-18 Sankyo Company, Limited Derive d'isoxazoleoxy
EP0621272B1 (fr) * 1993-04-21 1997-11-19 Tosoh Corporation 3,4-Dioxy-1,2,5-thiadiazoles en partie utiles comme fongicides
DK60493D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
CA2169839C (fr) * 1993-08-19 2002-06-11 Franklin Porter Bymaster Methode antipsychotique
UA43347C2 (uk) * 1993-08-19 2001-12-17 Ново Нордіск А/С Спосіб лікування психічних захворювань

Also Published As

Publication number Publication date
RU2158262C2 (ru) 2000-10-27
TW420680B (en) 2001-02-01
US5821370A (en) 1998-10-13
AU705047B2 (en) 1999-05-13
KR960014125A (ko) 1996-05-22
NO954239D0 (no) 1995-10-23
HU9503045D0 (en) 1995-12-28
FI955051A (fi) 1996-04-25
US5672709A (en) 1997-09-30
CO4480103A1 (es) 1997-07-09
US5929247A (en) 1999-07-27
US5646289A (en) 1997-07-08
JPH08225575A (ja) 1996-09-03
AU3439695A (en) 1996-05-02
NZ280300A (en) 1997-11-24
US5821371A (en) 1998-10-13
IL115717A0 (en) 1996-01-19
CN1145364A (zh) 1997-03-19
NO954239L (no) 1996-04-25
PE12697A1 (es) 1997-04-24
PL311077A1 (en) 1996-04-29
CA2161176A1 (fr) 1996-04-25
BR9504509A (pt) 1997-05-27
CZ275995A3 (en) 1996-08-14
YU66895A (sh) 1998-09-18
CN1048986C (zh) 2000-02-02
EP0709381A1 (fr) 1996-05-01
TR199501305A2 (tr) 1996-06-21
FI955051A0 (fi) 1995-10-23
HUT76347A (en) 1997-08-28
US5665745A (en) 1997-09-09

Similar Documents

Publication Publication Date Title
NO306949B1 (no) Azacykliske eller azabicykliske forbindelser samt farmasoeytiske preparater inneholdende slike forbindelser
NO965377D0 (no) Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene
NO179911C (no) Optisk aktivt 5H-pyrrolo[3,4-bÅpyrazinderivat samt farmasöytiske preparater inneholdende derivatet
DE69430029T2 (de) Navigationsanlage
DK162052C (da) D-2-aminoacyl-3-(z)-propenylcephalosporiner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DE69419026T2 (de) Behälterverschluss
NO932125D0 (no) Gyroskopisk maaleanordning
DE3578422D1 (de) 3-substituierte carbacephem-verbindung und sie enthaltende pharmazeutische zusammensetzung.
DE69524734D1 (de) Kindergesicherte behälterverschlussanordnung
DK13089A (da) Substituerede 5,6,7,8-tetrahydro-4h-thieno-(2,3-d)azepin-forbindelser, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
NO941915D0 (no) Madikament for nervebeskyttelse
DE69418077D1 (de) Organosiliziumverbindungen
DK266289A (da) Substituerede 2-ethenyl-3,4,5,6-tetrahydrofuro(4,3,2-ef)(3)benzazepinforbindelser, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
NO940533D0 (no) Rensede streptograminer, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
FI931279A (fi) Anordning foer tillslutning av en container
FI962007A (fi) Yhteensovitettavia aineita
DK141784D0 (da) Penemforbindelser,fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
ITTO930596A0 (it) Traduttore per elettroterapia
KR900014202U (ko) 코헤르 보호용기
BR9404399A (pt) Recipiente
IL83177A0 (en) Pharmaceutical compositions containing xylometazoline
KR950013225U (ko) 약탕 증류기
IT228333Y1 (it) Tornello rotante per bussole
FI930662A0 (fi) Foerfarande foer aostadkommande av ett luftuppvaermningssystem i rumsutrymmen samt anordningar foer detta
KR950034148U (ko) 예습복습의 공부를 할 수 있는 광고지

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2002